AMN Healthcare Services Inc (AMN) carries a Roarable Rating of D+ (Sell) with 53/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
AMN Healthcare Services Inc (AMN) advanced +0.47% to $46.94, trading at 92% of its 52-week range ($14.97 – $49.62). Stretched risk/reward at current multiples (-7% return on capital) under elevated 10-year interest-rate pressure.
SPS Commerce (SPSC) delivered earnings and revenue surprises of +13.93% and +0.17%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
AMN vs. TRI: Which Stock Is the Better Value Option?
Here is how AMN Healthcare Services (AMN) and Sodexo S.A. Sponsored ADR (SDXAY) have performed compared to their sector so far this year.
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro developments. As such, inves
AMN Healthcare Services has delivered a sharp rebound in 2026, and the jump in the share price puts fresh attention on whether the cash flows of the business are enough to support where the stock now trades. After a vola
AMN Healthcare (AMN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -8.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on AMN today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for AMN. Explore sector supply chains on /butterfly.
Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, AMN Healthcare Services Inc (AMN) ranks #584 by composite RQD confidence (53/100, grade D+) and #425 by equity capitalization ($1.82B). Within this direct 5-issuer industry benchmark cohort, ICFI leads on earnings valuation at 18.7x trailing P/E, while ICFI leads on capital efficiency and profitability with 8.1% ROIC and 37.2% gross margin. ICFI currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with AMN at 53/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| AMN
ACTIVE
AMN Healthcare Services Inc | D+ | 53/100 | — | 28.3% | -7.2% | +0.47% | $1.82B | Benchmark Subject |
| ASTH Astrana Health Inc. | D+ | 58/100 | 75.7x | — | 4.6% | -0.14% | $1.82B | /asth-vs-amn → |
| NSP Insperity Inc. | E | 20/100 | — | 13.2% | -8.9% | -10.38% | $1.77B | /nsp-vs-amn → |
| ICFI ICF International Inc. | B- | 71/100 | 18.7x | 37.2% | 8.1% | +1.25% | $1.72B | /icfi-vs-amn → |
| MAN ManpowerGroup | D- | 41/100 | — | 16.7% | 5.3% | -0.57% | $2.12B | /man-vs-amn → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), AMN Healthcare Services Inc (AMN) reported GAAP revenue of $2.73B (-8.5% vs. FY2024 revenue of $2.98B , and -27.9% cumulative change since FY2023) , GAAP net income of -$95.7M, operating cash flow of $269.5M, and free cash flow of $233.8M (-2.4% YoY). On the balance sheet, AMN closed FY2025 with $2.09B in total assets against $0 in total debt (Altman Z-Score: 2.76, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $2.73B | -$95.7M | $269.5M | $233.8M | $2.09B | — |
| FY2024 (FY) | 2024-12-31 | $2.98B | -$147.0M | $320.4M | $239.5M | $2.42B | — |
| FY2023 (FY) | 2023-12-31 | $3.79B | $210.7M | $372.2M | $372.2M | — | — |
As of 2026-11-01, AMN Healthcare Services Inc (NYSE: AMN) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $46.94 (+0.47% 1D, market cap $1.82B). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 14/20, and SEC Balance-Sheet Forensics 9/20. Across 1011 tracked Consumer Discretionary issuers, AMN ranks #584 in composite RQD confidence.
Within the Consumer Discretionary sector (Professional Services), AMN carries a Roarable D+ (53/100 RQD), trailing P/E of N/A, gross margin of 28.3%, and ROIC of -7.2%. By comparison, ASTH (Astrana Health Inc.) holds a D+ grade (58/100 RQD, P/E 75.7x, ROIC 4.6%, cap $1.82B) and NSP (Insperity Inc.) posts a E grade (20/100 RQD, P/E N/A, ROIC -8.9%, cap $1.77B). Among the 5-stock peer group, ICFI leads on earnings multiple (18.7x) while ICFI leads on capital efficiency (8.1% ROIC).
Per AMN's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001142750), AMN Healthcare Services Inc generated $2.73B in revenue (-8.5% YoY), -$95.7M in net income, and $233.8M in free cash flow against $2.09B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
AMN last traded at $46.94 (+0.47% on volume of 498,646 shares), positioning the stock +26.15% above its 50-day simple moving average ($37.21) and +64.93% above its 200-day simple moving average ($28.46). Across its 52-week range of $14.97 to $49.62, AMN sits at the 92.3% percentile with a 14-day RSI of 75.9 (OVERBOUGHT (>70)) and an implied next-earnings move of ±10.3% ($42.11 to $51.77).
Why AMN Stock advanced +0.47% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-7% return on capital) under elevated 10-year interest-rate pressure.